MED (Medifast) FFO


MED Medifast Inc MED
69 GF Score
Price $10.36
GF Value $8.75
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Medifast FFO?

FFO (Funds from operations) only applies to REITs.

MED
69GF Score
Medifast Inc MED
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Medifast (MED) Overvalued in 2026?

Based on GuruFocus' analysis, Medifast stock appears to be overvalued. The current stock price of $10.36 is trading 18.4% above its estimated GF Value™ of $8.75. GuruFocus considers Medifast to be Modestly Overvalued.

Key valuation signals for MED:

  • FFO:
  • GF Value™: $8.75 vs. price of $10.36 (18.4% above fair value)
  • GF Score™: 69/100 with 2 warning signs

No single metric tells the full story. See the MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medifast Business Description

Other Exchanges 0K05:UKMDF:Germany
Address 100 International Drive, Baltimore, MD, USA, 21202
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
69GF Score

Get the complete analysis for MED

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.36
Price
$8.75
GF Value